synergychc.com (SNYR) - Koefisien utang jangka dawa marang modal

Synergy CHC - logo grafis emiten SNYR

Synergy CHC Corp (SNYR) is increasing the margins of its niche wellness brands through an AI accelerator and influencers. The long-term debt-to-equity trajectory visualizes financial stability, where 0.00 shows the current value of the metric. The holding company is monetizing healthy lifestyle trends by updating vitamin formulations, while consistent plant utilization and the modernization of packaging lines minimize operating expenses.

synergychc.com (SNYR): Utang jangka dawa marang ekuitas saka 24.10.2024 nganti 03.10.2026
Produk mawa merek Synergy CHC Corp.

The deployment of robotic systems and RPA bots at Synergy CHC Corp. (SNYR) requires significant capital expenditures, which is reflected in the long-term debt-to-equity ratio. This metric assesses the ratio of liabilities with a maturity of over one year to equity. The indicator measures the degree of financial leverage, determining the business's reliance on borrowed financing. An increase in this figure signals a risk of losing financial stability. Market consensus utilizes this coefficient to evaluate the company's long-term solvency.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal KVUE|VRNA (Verona Pharma Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MENS (Jyong Biotech Ltd)|Utang jangka dawa marang modal ligand.com LGND|AMRX - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Liquidia Inc.|GLPG (Galapagos NV) - Utang jangka dawa marang modal|Utang jangka dawa marang modal anipharmaceuticals.com|Rasio utang jangka dawa marang ekuitas MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Pacira PCRX|ARS Corp (SPRY) - Kewajiban jangka dawa marang modal|TBPH: Rasio utang jangka dawa marang ekuitas|aquestive.com - Rasio silihan jangka dawa marang modal|SCPH: Utang jangka dawa marang modal|Tectonic Therapeutic - Koefisien utang jangka dawa marang modal|TNXP (Tonix Pharmaceuticals Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal SXT China SXTC|Utang jangka dawa marang ekuitas Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas eXoZymes EXOZ|Rasio tanggungan utang jangka dawa marang modal Oramed (ORMP)|ENTX: Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal MindWalk Therapeutics|ABVC BioPharma (ABVC) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal CPIX|QNTM (Quantum BioPharma) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal FibroGen Inc FGEN|Utang jangka dawa marang ekuitas Telomir Pharma (TELO)|RANI (ranitherapeutics.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RLYB (Rallybio)|Tanggungan utang jangka dawa marang ekuitas Lexaria Bioscience Corp|PULM: Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Pheton Holdings Ltd|APM (aptorumgroup.com) - Rasio utang jangka dawa marang ekuitas|Lyra Therapeutics Inc - Koefisien utang jangka dawa marang modal|IBO (Impact BioMedical Inc) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas TNF Pharma (TNFA)|Utang jangka dawa marang modal YCBD|PRFX (PainReform Ltd) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal CYTO (Altamira Therapeutics Ltd.)|LIPO - Rasio utang jangka dawa marang ekuitas|OPTN: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PIRS (pieris.com)|PROC: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Petros Pharmaceuticals Inc|Utang jangka dawa marang ekuitas Qilian International Holding Group Limited|Kewajiban jangka dawa marang modal ACELYRIN Inc. SLRN|Utang jangka dawa marang ekuitas TFF Pharmaceuticals (TFFP)